News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Edward Tuttle

Advertisement

Articles by Edward Tuttle

The Fruits of Comparative Effectiveness

ByEdward Tuttle,Justin Works,Anita Chawla,Dave Nellesen
November 18th 2010

New CER tools grant payers the evidence they need to control drug costs

Advertisement

Latest Updated Articles

  • The Fruits of Comparative Effectiveness
    The Fruits of Comparative Effectiveness

    November 18th 2010



Advertisement
Advertisement

Trending on PharmExec

1

Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees

2

Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report

3

Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty

4

Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees

5

Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us